Ascend Wellness Holdings, Inc. (OTC:AAWH - Free Report) - Investment analysts at Echelon Wealth Partners reduced their Q3 2024 earnings estimates for Ascend Wellness in a research report issued to clients and investors on Tuesday, May 7th. Echelon Wealth Partners analyst A. Semple now expects that the company will earn ($0.04) per share for the quarter, down from their prior estimate of ($0.03). The consensus estimate for Ascend Wellness' current full-year earnings is ($0.15) per share. Echelon Wealth Partners also issued estimates for Ascend Wellness' FY2024 earnings at ($0.17) EPS.
Separately, Needham & Company LLC reaffirmed a "hold" rating on shares of Ascend Wellness in a report on Tuesday.
Get Our Latest Report on AAWH
Ascend Wellness Stock Performance
Shares of AAWH stock traded down $0.02 during trading hours on Friday, reaching $1.30. The stock had a trading volume of 65,826 shares, compared to its average volume of 253,033. Ascend Wellness has a twelve month low of $0.46 and a twelve month high of $1.82. The company has a debt-to-equity ratio of 2.08, a current ratio of 2.47 and a quick ratio of 1.44. The firm has a market capitalization of $268.70 million, a PE ratio of -5.42 and a beta of 1.95. The firm has a 50-day simple moving average of $1.27 and a 200-day simple moving average of $1.27.
Ascend Wellness Company Profile
(
Get Free Report)
Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.
See Also
Before you consider Ascend Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ascend Wellness wasn't on the list.
While Ascend Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report